Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model.
BACKGROUND
There is increasing interest in the environmental and health consequences of silver nanoparticles as the use of this material becomes widespread. Although human exposure to nanosilver is increasing, only a few studies address possible toxic effect of inhaled nanosilver. The objective of this study was to determine whether very small commercially available nanosilver induces pulmonary toxicity in mice following inhalation exposure.


RESULTS
In this study, mice were exposed sub-acutely by inhalation to well-characterized nanosilver (3.3 mg/m³, 4 hours/day, 10 days, 5 ± 2 nm primary size). Toxicity was assessed by enumeration of total and differential cells, determination of total protein, lactate dehydrogenase activity and inflammatory cytokines in bronchoalveolar lavage fluid. Lungs were evaluated for histopathologic changes and the presence of silver. In contrast to published in vitro studies, minimal inflammatory response or toxicity was found following exposure to nanosilver in our in vivo study. The median retained dose of nanosilver in the lungs measured by inductively coupled plasma-optical emission spectroscopy (ICP-OES) was 31 μg/g lung (dry weight) immediately after the final exposure, 10 μg/g following exposure and a 3-wk rest period and zero in sham-exposed controls. Dissolution studies showed that nanosilver did not dissolve in solutions mimicking the intracellular or extracellular milieu.


CONCLUSIONS
Mice exposed to nanosilver showed minimal pulmonary inflammation or cytotoxicity following sub-acute exposures. However, longer term exposures with higher lung burdens of nanosilver are needed to ensure that there are no chronic effects and to evaluate possible translocation to other organs.
Department of Chemistry, University of Iowa, Iowa City, IA 52242, USA.
Larissa V
LV
Stebounova
Andrea
A
Adamcakova-Dodd
Jong Sung
JS
Kim
Heaweon
H
Park
Patrick T
PT
O'Shaughnessy
Vicki H
VH
Grassian
Peter S
PS
Thorne
D000280:Administration, Inhalation; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000139:chemically induced*; D019570:Inhalation Exposure; D008168:Lung / Q000166:cytology / Q000187:drug effects* / Q000473:pathology; D016676:Macrophages, Alveolar / Q000166:cytology / Q000187:drug effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D053758:Nanoparticles / Q000633:toxicity*; D012834:Silver / Q000737:chemistry* / Q000633:toxicity*; D014961:X-Ray Diffraction
D016207:Cytokines; D012834:Silver
Immunity. 2003 Nov;19(5):641-4
14614851
Exp Toxicol Pathol. 2005 Jul;57 Suppl 1:233-8
16092731
Inhal Toxicol. 2000 Jan;12 Suppl 3:291-9
26368628
Am J Respir Cell Mol Biol. 2008 Mar;38(3):371-6
17947511
Environ Sci Technol. 2010 Mar 15;44(6):2169-75
20175529
ACS Nano. 2008 Oct 28;2(10):2121-34
19206459
Acta Biomater. 2007 May;3(3):351-8
17275430
J Occup Environ Hyg. 2009 Feb;6(2):73-81
19034793
Environ Health Perspect. 2007 Mar;115(3):397-402
17431489
Inhal Toxicol. 2008 Apr;20(6):575-83
18444010
J Environ Monit. 2009 Oct;11(10):1774-81
19809700
Inhal Toxicol. 2003 Mar;15(3):251-63
12579456
Nanomedicine. 2007 Mar;3(1):95-101
17379174
Environ Health Perspect. 2001 Aug;109 Suppl 4:547-51
11544161
Toxicol Lett. 2008 Jan 4;176(1):1-12
18022772
Part Fibre Toxicol. 2009 Apr 30;6:14
19405955
Part Fibre Toxicol. 2009 Dec 16;6:32
20015351
Sci Total Environ. 2009 Jun 15;407(13):4184-8
19297010
ACS Nano. 2009 Feb 24;3(2):279-90
19236062
J Environ Monit. 2003 Aug;5(4):675-80
12948248
Toxicol Sci. 2009 Apr;108(2):452-61
19033393
Environ Sci Technol. 2008 Dec 1;42(23):8959-64
19192825
Environ Sci Technol. 2010 Dec 15;44(24):9571-7
21082828
Toxicol In Vitro. 2005 Oct;19(7):975-83
16125895
Toxicol Sci. 2000 May;55(1):24-35
10788556
Environ Sci Technol. 2010 Apr 1;44(7):2299-304
20192166
Eur Respir J. 2006 Jun;27(6):1096-102
16510455
Toxicol Sci. 2007 May;97(1):163-80
17301066
Toxicol Sci. 2006 Aug;92(2):456-63
16714391
Fundam Appl Toxicol. 1997 Dec;40(2):220-7
9441718
Environ Sci Technol. 2006 Jul 15;40(14):4374-81
16903273
Toxicol Appl Pharmacol. 2010 Jan 1;242(1):56-65
19796648
Inhal Toxicol. 2007 Aug;19(10):857-71
17687717
J Air Waste Manag Assoc. 2010 Jul;60(7):770-81
20681424
Am J Respir Crit Care Med. 2006 Apr 1;173(7):759-68
16387809
Inhal Toxicol. 2008 Apr;20(6):567-74
18444009
Inhal Toxicol. 2006 Sep;18(10):795-801
16774869
Environ Pollut. 2008 Nov;156(2):233-9
18824285
Toxicol Lett. 2008 Nov 10;182(1-3):24-8
18782608
Small. 2009 Aug 17;5(16):1897-910
19437466